patents.google.com

AU2003231478A1 - Novel protein, its dna and use thereof - Google Patents

  • ️Tue Dec 02 2003

AU2003231478A1 - Novel protein, its dna and use thereof - Google Patents

Novel protein, its dna and use thereof

Info

Publication number
AU2003231478A1
AU2003231478A1 AU2003231478A AU2003231478A AU2003231478A1 AU 2003231478 A1 AU2003231478 A1 AU 2003231478A1 AU 2003231478 A AU2003231478 A AU 2003231478A AU 2003231478 A AU2003231478 A AU 2003231478A AU 2003231478 A1 AU2003231478 A1 AU 2003231478A1 Authority
AU
Australia
Prior art keywords
dna
novel protein
protein
novel
Prior art date
2002-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231478A
Inventor
Nobuyuki Koyama
Kenichi Noguchi
Masayuki Takizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2002-05-17
Filing date
2003-05-15
Publication date
2003-12-02
2003-05-15 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
2003-12-02 Publication of AU2003231478A1 publication Critical patent/AU2003231478A1/en
Status Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003231478A 2002-05-17 2003-05-15 Novel protein, its dna and use thereof Abandoned AU2003231478A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002-143464 2002-05-17
JP2002143464 2002-05-17
JP2002-178777 2002-06-19
JP2002178777A JP2004041003A (en) 2002-05-17 2002-06-19 New protein, its dna and use thereof
PCT/JP2003/006057 WO2003097686A1 (en) 2002-05-17 2003-05-15 Novel protein, its dna and use thereof

Publications (1)

Publication Number Publication Date
AU2003231478A1 true AU2003231478A1 (en) 2003-12-02

Family

ID=29552303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231478A Abandoned AU2003231478A1 (en) 2002-05-17 2003-05-15 Novel protein, its dna and use thereof

Country Status (3)

Country Link
JP (1) JP2004041003A (en)
AU (1) AU2003231478A1 (en)
WO (1) WO2003097686A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022047A1 (en) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Binding partner of the placental growth factor, in particular antibodies directed against the placental growth factor, their production and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392428A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences Inc. Nucleic acids, proteins, and antibodies
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
JP2004530412A (en) * 2000-10-27 2004-10-07 インサイト・ゲノミックス・インコーポレイテッド Cytoskeleton-related proteins
EP1338649A4 (en) * 2000-10-30 2004-10-13 Takeda Chemical Industries Ltd NEW GENE OVEREXPRESSED IN THE HEART AND MUSCLES AND ITS USE

Also Published As

Publication number Publication date
JP2004041003A (en) 2004-02-12
WO2003097686A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
AU2002314181A1 (en) 2003-03-03 Novel endothelially expressed dnas and proteins, and their use
AU2003235096A1 (en) 2003-11-10 Novel protein and dna thereof
AU2003280992A1 (en) 2004-02-02 Novel proteins and use thereof
AU2003231478A1 (en) 2003-12-02 Novel protein, its dna and use thereof
AU2003262080A1 (en) 2004-04-30 Novel protein and dna thereof
AU2003292774A1 (en) 2004-07-22 Novel proteins and use thereof
AU2003203266A1 (en) 2003-09-02 Novel protein, its dna and use thereof
AU2003258658A1 (en) 2004-03-19 Improved dna and proteins
AU2003236041A1 (en) 2003-10-27 Novel protein and dna thereof
AU2003292721A1 (en) 2004-07-29 Novel protein and its gene
AU2003211722A1 (en) 2003-09-09 Novel proteins, dnas thereof and use of the same
AU2002344618A1 (en) 2003-05-12 Novel protein, its dna and use thereof
AU2003289385A1 (en) 2004-07-09 Novel protein and dna thereof
AU2003280641A1 (en) 2004-05-25 Novel protein and dna thereof
AU2003272946A1 (en) 2004-05-04 Novel protein and dna thereof
AU2003275712A1 (en) 2004-05-25 H17t213-transgenic animal, novel h17t213 protein and dna thereof
AU2003220067A1 (en) 2003-09-22 Jade nucleic acids, proteins and uses thereof
GB0105922D0 (en) 2001-04-25 Genes and proteins, and their use
AU2003211562A1 (en) 2003-09-09 Novel dna and use thereof
AU2002239056A1 (en) 2002-10-21 Novel protein, dna thereof and use of the same
EP1602666A4 (en) 2006-05-24 Novel protein and its dna
AU2003235099A1 (en) 2003-11-10 Novel proteins and dnas encoding the same
AU2003227428A1 (en) 2003-11-03 Novel proteins and dnas encoding the same
AU2002323918A1 (en) 2003-03-03 Novel protein and its dna
AU2002238745A1 (en) 2002-09-24 Genes and proteins, and their use

Legal Events

Date Code Title Description
2005-02-03 MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase